The antigenic repertoire of premalignant and high-risk lesions.
about
The Promise of Preventive Cancer VaccinesClinical significance of tumor-infiltrating lymphocytes in breast cancerThe FDA guidance on therapeutic cancer vaccines: the need for revision to include preventive cancer vaccines or for a new guidance dedicated to themCancer Prevention: Lessons Learned and Future Directions.Cancer prevention in the era of precision oncology.The dawn of vaccines for cancer prevention.
P2860
The antigenic repertoire of premalignant and high-risk lesions.
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
The antigenic repertoire of premalignant and high-risk lesions.
@ast
The antigenic repertoire of premalignant and high-risk lesions.
@en
type
label
The antigenic repertoire of premalignant and high-risk lesions.
@ast
The antigenic repertoire of premalignant and high-risk lesions.
@en
prefLabel
The antigenic repertoire of premalignant and high-risk lesions.
@ast
The antigenic repertoire of premalignant and high-risk lesions.
@en
P2860
P1476
The antigenic repertoire of premalignant and high-risk lesions.
@en
P2093
Mary L Disis
Sasha E Stanton
P2860
P304
P356
10.1158/1940-6207.CAPR-14-0314
P577
2015-01-08T00:00:00Z